Literature DB >> 15951935

Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan.

Jyh-Cherng Yu1, Giu-Cheng Hsu, Chung-Bo Hsieh, Lai-Fa Sheu, Tsu-Yi Chao.   

Abstract

We aimed to determine how to approach the axilla after finding a positive sentinel node (SN) for a woman with breast cancer in Taiwan. We used blue dye staining to identify the SN in 824 procedures on 811 patients with breast cancer small than 3 cm by a single surgeon. All patients underwent SN biopsy, followed by at least level II axillary dissection. All SNs were evaluated histologically and immunohistochemically with anti-cytokeratin antibodies. Non-SNs were examined by routine histology. SNs were identified in 814/824 procedures (98.8%). SN metastases were found in 286/814 (35.1%). Subsequent axillary dissections revealed tumors in non-SNs in 188 (65.7%) of these patients. There was a relatively high incidence of non-SN metastases in our population. Tumor exhibiting high nuclear grading, ER-, PR-, Erb-2/neu overexpression, lymphovascular invasion, increasing tumor size, multiple positive SNs, and macrometastatic size in SNs (> 2 mm) were all significantly correlated with non-SN metastases. Multivariate analysis showed that tumor size, the number of positive SNs, and the metastatic size in SNs were independent factors predicting the presence of positive non-SNs. Small (< 2 cm) cancers, having only micrometastatic foci in the SN and having only one SN involved are closely correlated with the tumor-free non-SNs. Our data will assist such patients regarding the need for axillary dissection after finding a positive SN.

Entities:  

Mesh:

Year:  2005        PMID: 15951935     DOI: 10.1007/s00268-005-7744-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  36 in total

1.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

2.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

3.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

4.  A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping.

Authors:  Walter D Blessing; Alan J Stolier; Stephen C Teng; John S Bolton; George M Fuhrman
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

5.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

6.  Unique features of breast cancer in Taiwan.

Authors:  S H Cheng; M H Tsou; M C Liu; J J Jian; J C Cheng; S Y Leu; C Y Hsieh; A T Huang
Journal:  Breast Cancer Res Treat       Date:  2000-10       Impact factor: 4.872

7.  Predictors of nonsentinel lymph node metastasis in breast cancer patients.

Authors:  Ulka Sachdev; Kara Murphy; Alain Derzie; Shabnam Jaffer; Ira J Bleiweiss; Steven Brower
Journal:  Am J Surg       Date:  2002-03       Impact factor: 2.565

8.  Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.

Authors:  J-P Travagli; D Atallah; M-C Mathieu; F Rochard; S Camatte; J Lumbroso; J-R Garbay; R Rouzier
Journal:  Eur J Surg Oncol       Date:  2003-05       Impact factor: 4.424

9.  Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients.

Authors:  Cynthia Cohen; Naomi Alazraki; Toncred Styblo; Sandra M Waldrop; Sandra F Grant; Travis Larsen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-12

Review 10.  Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes.

Authors:  M Noguchi
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

View more
  3 in total

1.  Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Authors:  J L Fougo; M Afonso; F Senhorães Senra; T Dias; C Leal; C Araújo; M Dinis-Ribeiro
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

Review 2.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.

Authors:  Carolien H M van Deurzen; Maaike de Boer; Evelyn M Monninkhof; Peter Bult; Elsken van der Wall; Vivianne C G Tjan-Heijnen; Paul J van Diest
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

3.  New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.

Authors:  Holbrook E Kohrt; Richard A Olshen; Honnie R Bermas; William H Goodson; Douglas J Wood; Solomon Henry; Robert V Rouse; Lisa Bailey; Vicki J Philben; Frederick M Dirbas; Jocelyn J Dunn; Denise L Johnson; Irene L Wapnir; Robert W Carlson; Frank E Stockdale; Nora M Hansen; Stefanie S Jeffrey
Journal:  BMC Cancer       Date:  2008-03-04       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.